French watchdogs allow Cerba to buy biomed rival Bio 7

MLex Summary: The French competition authority has cleared the acquisition of the medical biology group Bio 7 group by its rival Cerba, finding that it is not likely to harm competition....

Already a subscriber? Click here to view full article